Monocyte activation by circulating fibronectin fragments in HIV-1-infected patients

Journal of Immunology

Volumn 173, Issue 3, 2004, Pages 2190-2198

  Trial, JoAnn ^a,b   Rubio, Jose A ^a,b   Birdsall, Holly H ^a,b   Rodriguez Barradas, Maria ^b   Rossen, Roger D ^a,b  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA5 INTEGRIN; CD11B ANTIGEN; CD86 ANTIGEN; FIBRONECTIN; PADGEM PROTEIN; PROTEINASE INHIBITOR;

ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; ELECTROPHORESIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE FUNCTION; MAJOR CLINICAL STUDY; MONOCYTE; PRIORITY JOURNAL;

EID: 3242796750     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.3.2190     Document Type: Article

References (52)

1. Bandres, J. C., J. Trial, D. M. Musher, and R. D. Rossen. 1993. Increased phagocytosis and generation of reactive oxygen products by neutrophils and monocytes of men with stage 1 human immunodeficiency virus infection. J. Infect. Dis. 168:75.
2. Dobmeyer, T. S., B. Raffel, J. M. Dobmeyer, S. Findhammer, S. A. Klein, D. Kabelitz, D. Hoelzer, E. B. Helm, and R. Rossol. 1995. Decreased function of monocytes and granulocytes during HIV-1 infection correlates with CD4 cell counts. Eur. J. Med. Res. 1:9.
3. Trial, J., H. H. Birdsall, J. A. Hallum, M. L. Crane, M. C. Rodriguez-Barradas, A. L. de Jong, B. Krishnan, C. E. Lacke, C. G. Figdor, and R. D. Rossen. 1995. Phenotypic and functional changes in peripheral blood monocytes during progression of human immunodeficiency viras infection: effects of soluble immune complexes, cytokines, subcellular particulates from apoptotic cells, and HIV-1-encoded proteins on monocytes phagocytic function, oxidative burst, transendothelial migration, and cell surface phenotype. J. Clin. Invest. 95:1690.
4. Wahl, L. M., M. L. Corcoran, S. W. Pyle, L. O. Arthur, B. A. Harel, and W. L. Farrar. 1989. Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. Proc. Natl. Acad. Sci. USA 86:621.
5. Pos, O., A. Stevenhagen, P. L. Meenhorst, F. P. Kroon, and R. Van Furth. 1992. Impaired phagocytosis of Staphylococcus aureus by granulocytes and monocytes of AIDS patients. Clin. Exp. Immunol. 88:23.
6. Baqui, A. A., T. F. Meiller, M. Zhang, and W. A. Falkler, Jr. 1999. The effects of HIV viral load on the phagocytic activity of monocytes activated with lipopolysaccharide from oral microorganisms. Immunopharmacol. Immunotoxicol. 21:421.
7. Baldwin, G. C., J. Fleischmann, Y. Chung, Y. Koyanagi, I. S. Chen, and D. W. Golde. 1990. Human immunodeficiency virus causes mononuclear phagocyte dysfunction. Proc. Natl. Acad. Sci. USA 87:3933.
8. Roilides, E., D. Venzon, P. A. Pizzo, and M. Rubin. 1990. Effects of antiretroviral dideoxynucleosides on polymorphonuclear leukocyte function. Antimicrob. Agents Chemother. 34:1672.
9. Mastroianni, C. M., M. Lichtner, F. Mengoni, C. D'Agostino, G. Forcina, G. d'Ettorre, P. Santopadre, and V. Vullo. 1999. Improvement in neutrophil and monocyte function during highly active antiretroviral treatment of HIV-1-infected patients. AIDS 13:883.
10. Pietrella, D., C. Monari, C. Retini, B. Palazzetti, F. Bistoni, and A. Vecchiarelli. 1998. Human immunodeficiency virus type 1 envelope protein gp120 impairs intracellular antifungal mechanisms in human monocytes. J. Infect. Dis. 177:347.
11. Stellbrink, H. J., J. van Lunzen, M. Westby, E. O'Sullivan, C. Schneider, A. Adam, L. Weitner, B. Kuhlmann, C. Hoffmann, S. Fenske, et al. 2002. Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial). AIDS 16:1479.
12. Weeks, B. S., M. E. Klotman, E. Holloway, W. G. Stetler-Stevenson, H. K. Kleinman, and P. E. Klotman. 1993. HIV-1 infection stimulates T cell invasiveness and synthesis of the 92-kDa type IV collagenase. AIDS Res. Hum. Retroviruses 9:513.
13. Shoeman, R. L., R. Hartig, C. Hauses, and P. Traub. 2002. Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. Cell Biol. Int. 26:529.
14. Marshall, D. C., T. Wyss-Coray, and C. R. Abraham. 1998. Induction of matrix metalloproteinase-2 in human immunodeficiency virus-1 glycoprotein 120 transgenic mouse brains. Neurosci. Lett. 254:97.
15. Beezhold, D. H., and C. Personius. 1992. Fibronectin fragments stimulate tumor necrosis factor secretion by human monocytes. J. Leukocyte Biol. 51:59.
16. Chang, Z. L., D. H. Beezhold, C. D. Personius, and Z. L. Shen. 1993. Fibronectin cell-binding domain triggered transmembrane signal transduction in human monocytes. J. Leukocyte Biol. 53:79.
17. Morris, D. A., R. A. Clark, L. M. Swigart, J. C. Huff, W. L. Weston, and S. E. Howell. 1982. Fibronectin fragment(s) are chemotactic for human peripheral blood monocytes. J. Immunol. 129:1612.
18. Clark, R. A., N. E. Wikner, D. E. Doherty, and D. A. Morris. 1988. Cryptic chemotactic activity of fibronectin for human monocytes resides in the 120-kDa fibroblastic cell-binding fragment. J. Biol. Chem. 263:12115.
19. Czop, J. K., J. L. Radish, and K. F. Austen. 1981. Augmentation of human monocyte opsonin-independent phagocytosis by fragments of human plasma fibronectin. Proc. Natl. Acad. Sci. USA 78:3649.
20. Trial, J., R. E. Baughn, J. N. Wygant, B. W. McIntyre, H. H. Birdsall, K. A. Youker, A. Evans, M. L. Entman, and R. D. Rossen. 1999. Fibronectin fragments modulate monocyte VLA-5 expression and monocyte migration. J. Clin. Invest. 104:419.
21. 1-antitrypsin, and Fcγ receptors. J. Clin. Invest. 100:1416.
22. Trial, J., R. D. Rossen, J. Rubio, and A. A. Knowlton. 2004. Inflammation and ischemia: macrophages activated by fibronectin fragments enhance the survival of injured cardiac myocytes. Exp. Biol. Med. 229:538.
23. Csernok, E., M. Ernst, W. Schmitt, D. F. Bainton, and W. L. Gross. 1994. Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin. Exp. Immunol. 95:244.
24. Rao, N. V., B. C. Marshall, B. H. Gray, and J. R. Hoidal. 1993. Interaction of secretory leukocyte protease inhibitor with proteinase-3. Am. J. Respir. Cell Mol. Biol. 8:612.
25. van der Geld, Y. M., P. C. Limburg, and C. G. Kallenberg. 2001. Proteinase 3, Wegener's autoantigen: from gene to antigen. J. Leukocyte Biol. 69:177.
26. 1- proteinase inhibitor and antineutrophil cytoplasm antibodies (ANCA) in plasma. J. Immunol. Methods 175:215.
27. 2 macroglobulin in human serum: application to insulin-dependent diabetes mellitus. Clin. Immunol. Immunopathol. 89:247.
28. Musher, D. M., D. A. Watson, D. Nickeson, F. Gyorkey, C. Lahart, and R. D. Rossen. 1990. The effect of HIV infection on phagocytosis and killing of Staphylococcus aureus by human pulmonary alveolar macrophages. Am. J. Med. Sci. 299:158.
29. Powderly, W. G., A. Landay, and M. M. Lederman. 1998. Recovery of the immune system with antiretroviral therapy: the end of opportunism? JAMA 280:72.
30. Kedzierska, K., R. Azzam, P. Ellery. J. Mak, A. Jaworowski, and S. M. Crowe. 2003. Defective phagocytosis by human monocyte/macrophages following HIV-1 infection: underlying mechanisms and modulation by adjunctive cytokine therapy. J. Clin. Virol. 26:247.
31. Torre, D., M. Issi, C. Sampietro, G. P. Fiori, G. Chelazzi, and G. Ferraro. 1990. Plasma fibronectin concentrations in patients with human immunodeficiency virus infection. J. Clin. Pathol. 43:560.
32. Ogden, D. M., H. E. Fischer, F. J. Liu, A. Rios, and B. Lichtiger. 1988. Plasma fibronectin values in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Am. J. Clin. Pathol. 90:293.
33. Raffi, F., D. Boudart, D. Merrien, and J. H. Barrier. 1992. Fibronectin in HIV-infected patients: a prospective study. Eur. J. Med. 1:308.
34. + T lymphocytes. J. Immunol. 164:3236.
35. Greco, G., S. Pal, R. Pasqualini, and L. M. Schnapp. 2002. Matrix fibronectin increases HIV stability and infectivity. J. Immunol. 168:5722.
36. Doherty, D. E., P. M. Henson, and R. A. Clark. 1990. Fibronectin fragments containing the RGDS cell-binding domain mediate monocyte migration in the rabbit lung. J. Clin. Invest. 86:1065.
37. Czop, J. K., and K. F. Austen. 1982. Augmentation of phagocytosis by a specific fibronectin fragment that links particulate activators to the fibronectin adherence receptor of human monocytes. J. Immunol. 129:2678.
38. Takizawa, T., S. Nishinarita, N. Kitamura, J. Hayakawa, H. Kang, Y. Tomita, K. Mitamura, K. Yamagami, and T. Horie. 1995. Interaction of the cell-binding domain of fibronectin with VLA-5 integrin induces monokine production in cultured human monocytes. Clin. Exp. Immunol. 101:376.
39. Ruoslahti, E. 1988. Fibronectin and its receptors. Annu. Rev. Biochem. 57:375.
40. Ruoslahti, E. 1999. Fibronectin and its integrin receptors in cancer. Adv. Cancer Res. 76:1.
41. Hynes, R. O. 1992. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11.
42. Juliano, R. L. 2002. Signal transduction by cell adhesion receptors and the cytoskeleton: functions of integrins, cadherins, selectins, and immunoglobulin-superfamily members. Annu. Rev. Pharmacol. Toxicol. 42:283.
43. Mostafavi-Pour, Z., J. A. Askari, S. J. Parkinson, P. J. Parker, T. T. Ng, and M. J. Humphries. 2003. Integrin-specific signaling pathways controlling focal adhesion formation and cell migration. J. Cell Biol. 161:155.
44. Huynh, Q. N., S. Wang, E. Tafolla, S. A. Gansky, S. Kapila, G. C. Armitage, and Y. L. Kapila. 2002. Specific fibronectin fragments as markers of periodontal disease status. J. Periodontol. 73:1101.
45. Labat-Robert, J. 2002. Fibronectin in malignancy. Semin. Cancer Biol. 12:187.
46. Barilla, M. L., and S. E. Carsons. 2000. Fibronectin fragments and their role in inflammatory arthritis. Semin. Arthritis Rheum. 29:252.
47. Daudi, I., P. W. Gudewicz, T. M. Saba, E. Cho, and M. B. Frewin. 1991. Leukocyte elastase-independent proteolysis of gelatin-bound fibronectin by inflammatory macrophages. Inflammation 15:481.
48. Daudi, I., P. W. Gudewicz, T. M. Saba, E. Cho, and P. Vincent. 1991. Proteolysis of gelatin-bound fibronectin by activated leukocytes: a role for leukocyte elastase. J. Leukocyte Biol. 50:331.
49. Wachtfogel, Y. T., W. Abrams, U. Kucich, G. Weinbaum, M. Schapira, and R. W. Colman. 1988. Fibronectin degradation products containing the cytoadhesive tetrapeptide stimulate human neutrophil degranulation. J. Clin. Invest. 81:1310.
50. Oswald, M., and K. von der Helm. 1991. Fibronectin is a non-viral substrate for the HIV proteinase. FEBS Lett. 292:298.
51. Birdsall, H., E. Siwak, J. Trial, M. Rodriguez-Barradas, A. J. White, S. Weitgrefe, and R. Rossen. 2002. Transendothelial migration of leukocytes carrying infectious HIV-1: an indicator of adverse prognosis. AIDS 16:5.
52. Birdsall, H. H., W. Porter, D. M. Green, J. Rubio, J. Trial, and R. D. Rossen. Impact of fibronectin fragments on the transendothelial migration of HIV-infected leukocytes and the development of subendothelial foci of infectious leukocytes. J. Immunol. in press.